Leila Alland - Sep 7, 2021 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
Chief Medical Officer
Signature
/s/ Winston Kung, by power of attorney
Stock symbol
PMVP
Transactions as of
Sep 7, 2021
Transactions value $
-$102,765
Form type
4
Date filed
9/8/2021, 04:22 PM
Previous filing
Aug 10, 2021
Next filing
Sep 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Options Exercise $15.2K +3.9K $3.90 3.9K Sep 7, 2021 Direct
transaction PMVP Common Stock Sale -$118K -3.9K -100% $30.25 0 Sep 7, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Employee Stock Option (right to buy) Options Exercise $0 -3.9K -1.09% $0.00 354K Sep 7, 2021 Common Stock 3.9K $3.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020.
F2 One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter.